Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 28/2/2020
SIETES contiene 92917 citas

 
 
<< anterior 21 a 40 de 684 siguiente >>
Presentar resultados
Seleccionar todas
22. Cita con resumen
Wise J. NICE approves immunotherapy combination for advanced melanoma. BMJ 2016;353:i3421. [Ref.ID 100435]
24.Tiene citas relacionadas Cita con resumen
Messerli FH, Bangalore S, Grossman E. Adverse effects and tolerability of ß blockers. BMJ 2016;353:i3142. [Ref.ID 100378]
25. Cita con resumen
Voelker R. New pancreatic cancer drug. JAMA 2015;314:2227. [Ref.ID 99728]
26. Cita con resumen
Anónimo. FDA approves costly ipilimumab-nivolumab combination for melanoma treatment. DIA Daily 2015:2 de octubre. [Ref.ID 99543]
27. Cita con resumen
Anónimo. FDA approves targeted therapy for first-line treatment of patients with a type of metastatic lung cancer. U.S. Food and Drug Administration 2015:13 de julio. [Ref.ID 99504]
28. Cita con resumen
Pi-Sunyer X, Astrup A, Fuijoka K, Greenway F, Halpern A, Krempf M, Lau DCW, le Roux CW, Ortiz RV, Jensen CB, Wilding JPH, for the SCALE Obesity and Prediabetes NN8022-1839 Study Group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 2015;373:11-22. [Ref.ID 99228]
30. Cita con resumen
Anónimo. FDA approves two drugs for treatment of IBS with diarrhea. DIA Daily 2015:28 de mayo. [Ref.ID 99106]
31. Cita con resumen
McDonald EG, Milligan J, Frenette C, Lee TD. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med 2015;175:784-91. [Ref.ID 99028]
32. Cita con resumen
33. Cita con resumen
Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis. J Allergy Clin Immunol 2015;135:745-52. [Ref.ID 98852]
34. Cita con resumen
Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Méek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:825-34. [Ref.ID 98811]
35. Cita con resumen
Mitjà O, Houinei W, Moses P, Kapa A, Paru R, Hays R, Lukehart S, Godornes C, Bieb SV, Grice T, Siba P, Mabey D, Sanz S, Alonso PL, Asiedu K, Bassat Q. Mass treatment with single-dose azithromycin for yaws. N Engl J Med 2015;372:703-10. [Ref.ID 98808]
36. Cita con resumen
Schumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukaris AG, Kiyota N, Taylor MH, Kim S-B, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI. Lenvatinib versus placebo in radiodiodine-refractory thyroid cancer. N Engl J Med 2015;372:621-30. [Ref.ID 98795]
37. Cita con resumen
Anónimo. Thyroid cancer treatment performs well in clinical trial, FDA approval expected. DIA Daily 2014:13 de febrero. [Ref.ID 98776]
38. Cita con resumen
Herzig SJ, Doughty C, Marchina S, Sanan N, Feng W, Kumar S. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia. Ann Neurol 2014;76:712-8. [Ref.ID 98376]
39. Cita con resumen
Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, Cortesi E, Tomasello G, Ronzoni M, Spadi R, Zaniboni A, Tonini G, Buonadonna A, Amoroso D, Chiara S, Carlomagno C, Boni C, Allegrini G, Boni L, Falcone A. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med 2014;371:1609-18. [Ref.ID 98245]
40. Cita con resumen
Anónimo. Sorafenib (Nexavar) for thyroid cancer. Med Lett Drugs Ther 2014;56:43-4. [Ref.ID 97918]
Seleccionar todas
 
<< anterior 21 a 40 de 684 siguiente >>